What is PharmaJet?
PharmaJet's core mission is the worldwide acceptance of its needle-free devices as the standard of care in vaccine delivery. The company's proprietary injectors are designed to be safe, fast, and easy to use, effectively eliminating the risks associated with needle-stick injuries, cross-contamination, and reducing sharps waste disposal. This focus on safety and efficiency positions PharmaJet as a key player in the medical technology and healthcare innovation sectors, aiming to improve patient outcomes and healthcare system sustainability.
How much funding has PharmaJet raised?
PharmaJet has raised a total of $38.7M across 10 funding rounds:
Unspecified
$9.1M
Unspecified
$4.2M
Unspecified
$3.4M
Unspecified
$2.8M
Unspecified
$2.2M
Unspecified
$2.5M
Unspecified
$5.2M
Private Equity
$6M
Private Equity
$3M
Debt
$283K
Unspecified (2009): $9.1M, investors not publicly disclosed
Unspecified (2011): $4.2M, investors not publicly disclosed
Unspecified (2011): $3.4M, investors not publicly disclosed
Unspecified (2012): $2.8M, investors not publicly disclosed
Unspecified (2012): $2.2M, investors not publicly disclosed
Unspecified (2013): $2.5M, investors not publicly disclosed
Unspecified (2013): $5.2M, investors not publicly disclosed
Private Equity (2015): $6M, investors not publicly disclosed
Private Equity (2017): $3M, investors not publicly disclosed
Debt (2021): $283K backed by PPP
What's next for PharmaJet?
With this substantial enterprise-level backing, PharmaJet is poised for accelerated growth and market penetration. The capital infusion is expected to fuel further research and development, enhance manufacturing capabilities, and expand its global distribution network. The company's strategic objective to establish its needle-free technology as a global standard of care will likely see increased investment in clinical validation, regulatory approvals, and market education initiatives. This financing round signals a critical phase for PharmaJet as it scales its operations to meet the growing demand for safer and more effective vaccine administration solutions.
See full PharmaJet company page
